Sian Bigora - Apr 5, 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Apr 5, 2024
Transactions value $
-$1,411
Form type
4
Date filed
8/2/2024, 05:34 PM
Previous filing
Apr 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1.68K +8.31% 21.8K Apr 5, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$1.03K -368 -1.69% $2.79 21.5K Apr 5, 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +3% 22.1K Jul 10, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$385 -225 -1.02% $1.71 21.9K Jul 10, 2024 Direct
holding PCSA Common Stock 6.67K Apr 5, 2024 By CorLyst, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +3.23K +15.04% $0.00 24.7K Jun 28, 2024 Common Stock 3.23K $0.00 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2.43K +9.81% $0.00 27.2K Jun 28, 2024 Common Stock 2.43K $0.00 Direct F3
transaction PCSA Restricted Stock Units Award $0 +404 +1.49% $0.00 27.6K Jun 28, 2024 Common Stock 404 $0.00 Direct F4
transaction PCSA Restricted Stock Units Award $0 +404 +1.47% $0.00 28K Jun 28, 2024 Common Stock 404 $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.